These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 22417301)
1. MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop. Sinnberg T; Sauer B; Holm P; Spangler B; Kuphal S; Bosserhoff A; Schittek B Exp Dermatol; 2012 Apr; 21(4):265-70. PubMed ID: 22417301 [TBL] [Abstract][Full Text] [Related]
2. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells. Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949 [TBL] [Abstract][Full Text] [Related]
4. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392 [TBL] [Abstract][Full Text] [Related]
5. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Sutherland BW; Kucab J; Wu J; Lee C; Cheang MC; Yorida E; Turbin D; Dedhar S; Nelson C; Pollak M; Leighton Grimes H; Miller K; Badve S; Huntsman D; Blake-Gilks C; Chen M; Pallen CJ; Dunn SE Oncogene; 2005 Jun; 24(26):4281-92. PubMed ID: 15806160 [TBL] [Abstract][Full Text] [Related]
6. Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase-Akt-nuclear [corrected] factor kappa B signaling cascade in human melanoma cells. Lee J; Duk Jung I; Gyo Park C; Han JW; Young Lee H Melanoma Res; 2006 Oct; 16(5):445-52. PubMed ID: 17013094 [TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation by Akt disables the anti-oncogenic activity of YB-1. Bader AG; Vogt PK Oncogene; 2008 Feb; 27(8):1179-82. PubMed ID: 17704806 [TBL] [Abstract][Full Text] [Related]
9. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways. Yang XS; Liu S; Liu YJ; Liu JW; Liu TJ; Wang XQ; Yan Q J Cell Physiol; 2010 Nov; 225(2):612-9. PubMed ID: 20506505 [TBL] [Abstract][Full Text] [Related]
12. Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells. Domínguez-Cáceres MA; García-Martínez JM; Calcabrini A; González L; Porque PG; León J; Martín-Pérez J Oncogene; 2004 Sep; 23(44):7378-90. PubMed ID: 15286700 [TBL] [Abstract][Full Text] [Related]
13. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991 [TBL] [Abstract][Full Text] [Related]
14. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521 [TBL] [Abstract][Full Text] [Related]
16. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. St-Germain ME; Gagnon V; Parent S; Asselin E Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316 [TBL] [Abstract][Full Text] [Related]
17. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
18. The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1. Astanehe A; Finkbeiner MR; Hojabrpour P; To K; Fotovati A; Shadeo A; Stratford AL; Lam WL; Berquin IM; Duronio V; Dunn SE Oncogene; 2009 Jun; 28(25):2406-18. PubMed ID: 19430491 [TBL] [Abstract][Full Text] [Related]
19. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells. Lin KL; Tsai PC; Hsieh CY; Chang LS; Lin SR Chem Biol Interact; 2011 Nov; 194(2-3):148-58. PubMed ID: 22033475 [TBL] [Abstract][Full Text] [Related]
20. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells. Mut M; Lule S; Demir O; Kurnaz IA; Vural I Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]